NBP255521PE

Novus Biologicals™ ID1 Recombinant Protein Antigen

Manufacturer: Novus Biologicals™

Select a Size

Pack Size SKU Availability Price
Each of 1 NBP255521PE-Each-of-1 In Stock ₹ 31,372.50

NBP255521PE - Each of 1

₹ 31,372.50

In Stock

Quantity

1

Base Price: ₹ 31,372.50

GST (18%): ₹ 5,647.05

Total Price: ₹ 37,019.55

Gene ID (Entrez)

3397

Common Name

ID1 Recombinant Protein Antigen

Formulation

PBS and 1M Urea, pH 7.4.

Gene Alias

BHLHB24, bHLHb24DNA-binding protein inhibitor ID-1, Class B basic helix-loop-helix protein 24, dJ857M17.1.2, dJ857M17.1.2 (inhibitor of DNA binding 1, dominant negative helix-loop-helixprotein), ID, inhibitor of differentiation 1, Inhibitor of DNA binding

Label Type

Unlabeled

Quantity

100μL

Source

E.Coli

Purification Method

>80% by SDS-PAGE and Coomassie blue staining

Content And Storage

Store at −20°C. Avoid freeze-thaw cycles.

For Use With (Application)

Blocking/Neutralizing, Control

Gene Symbol

ID1

Product Type

Recombinant Protein Antigen

Regulatory Status

RUO

Specific Reactivity

This recombinant antigen is only intended to be used as a blocking agent to confirm antibody specificity with the corresponding antibody, catalog number NBP2-51721. It is purified by IMAC chromatography, and the expected concentration is greater than 0.5 mg/ml

Related Products

Img

Novus Biologicals™

NBP255302PE

--

Img

Novus Biologicals™

NBP255177PE

--

Img

Novus Biologicals™

NBP256040PE

--

Img

Novus Biologicals™

NBP255486PE

--

Img

Novus Biologicals™

NBP255667PE

--

Img

Novus Biologicals™

NBP256299PE

--

Img

Novus Biologicals™

NBP255760PE

--

Img

Novus Biologicals™

NBP255101PE

--

Description

  • A recombinant protein antigen with a N-terminal His6-ABP tag corresponding to human ID1
  • Source: E.coli Amino Acid Sequence: DYIRDLQLELNSESEVGTPGGRGLPVRAPLSTLNGEISALTAEAACVPADDRILCR The ID1 Recombinant Protein Antigen is derived from E
  • coli
  • The ID1 Recombinant Protein Antigen has been validated for the following applications: Antibody Competition.